NSE: JUBLINGREA · 27 October 2026
- Jubilant Ingrevia Ltd. shares advanced 4.21% today, settling at ₹631.50 after trading between an intraday low of ₹603.75 and a high of ₹658.40.
- Jubilant Ingrevia reported its financial results for the quarter ended September 30, 2026, posting a total revenue of ₹1,394 crore, up 24% year-on-year. Quarterly EBITDA grew 51% year-on-year to ₹221 crore, and net profit after exceptional items stood at ₹111 crore, reflecting a 61% increase compared to the corresponding period last year. Growth was supported by improved realizations and solid performance across the Specialty Chemicals, Nutrition, and Chemical Intermediates segments.
- Trading volume was 8.45 times the 20-day average daily volume.
Why is Jubilant Ingrevia share price rising on 27 October 2026?
Jubilant Ingrevia Ltd. shares advanced 4.21% today, settling at ₹631.50 after trading between an intraday low of ₹603.75 and a high of ₹658.40.
Relative to broader market benchmarks, the stock outperformed the Nifty index, which edged down by 0.02%, while matching the positive momentum seen in the Nifty Metal sector benchmark, which rose 0.39%. This session's gain helped offset recent consolidation, bringing the stock's 5-day return to 1.25%, even as its 20-day return remained negative at -3.75%.
The price movement coincided with the release of the company's financial results for the quarter and half year ended September 30, 2026, filed on October 27, 2026. Management reported an all-time high quarterly revenue of ₹1,394 crore, marking a 24% year-on-year increase, while EBITDA surged 51% year-on-year to ₹221 crore. Additionally, the company announced an agreement to acquire a 40% stake in ZettaOne Technologies Limited for ₹189.2 crore to expand into the Electronics Development and Manufacturing Services (EDMS) space.
20.77 lakh shares traded by 27 October 2026 · 02:55 PM IST. This compares with a 20-day average daily volume of 2.46 lakh shares (8.45 times). The five-day average daily volume was 1.97 lakh shares. Separately, the NSE report for 26 October 2026 showed 73,265 shares delivered, representing 54.84% of that day’s traded volume. The same report recorded 8,965 trades.
The stock's upward move aligns closely with the release of strong Q2 FY27 financial results showing a 24% jump in revenue and a 51% surge in EBITDA, alongside the announcement of a 40% stake acquisition in ZettaOne Technologies.
Latest Company Developments
Jubilant Ingrevia reported its financial results for the quarter ended September 30, 2026, posting a total revenue of ₹1,394 crore, up 24% year-on-year. Quarterly EBITDA grew 51% year-on-year to ₹221 crore, and net profit after exceptional items stood at ₹111 crore, reflecting a 61% increase compared to the corresponding period last year. Growth was supported by improved realizations and solid performance across the Specialty Chemicals, Nutrition, and Chemical Intermediates segments.
Strong quarterly earnings growth directly influences valuation and reflects the ongoing execution of the company's strategic roadmap.
The company announced that it has signed an agreement to acquire a 40% stake in ZettaOne Technologies Limited with an investment of ₹189.2 crore. ZettaOne operates in the Electronics Development and Manufacturing Services (EDMS) sector, offering integration into the broader electronics and semiconductor ecosystem. Management expects ZettaOne to grow significantly and broaden customer reach across semiconductor, aerospace, defense, and industrial electronics segments.
This strategic acquisition marks the company's entry into the EDMS space, creating new avenues for long-term growth and integrated customer offerings.
The company informed stock exchanges that Ms. Vinita Koul, Senior Vice President and Head of HR, tendered her resignation effective from the close of business hours on November 6, 2026, to pursue other interests. Management noted that transition arrangements are underway to ensure operational continuity.
Senior management departures require monitoring for leadership continuity, though it is a routine corporate transition rather than a direct valuation driver.
Outcome of Board Meeting held on October 01, 2026 for incorporation of a wholly owned subsidiary.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 22.59% on 30 September 2026. This compares with 22.39% on 30 June 2026, a change of +0.20 percentage points.
The filing reported 26 MF/UTI holders.
Research & Brokerage Views
Retained a 'Buy' rating anticipating sharp earnings growth ahead.
Maintained a positive view on the stock, citing expectations of a structural earnings inflection.
What to Watch Next
- Execution of the ZettaOne Technologies acquisition and integration into the electronics and semiconductor business segments.
- Progress on the commissioning of the new Multi-Purpose Plant by the end of the year.
- Volume and pricing trends across the Pyridine, Fine Chemicals, and Acetyls portfolios.
- Sustained delivery percentage and volume momentum relative to its 20-day average.
More Jubilant Ingrevia news and dated analysis →
Frequently Asked Questions
What is the latest Jubilant Ingrevia company news?
Jubilant Ingrevia reported its financial results for the quarter ended September 30, 2026, posting a total revenue of ₹1,394 crore, up 24% year-on-year. Quarterly EBITDA grew 51% year-on-year to ₹221 crore, and net profit after exceptional items stood at ₹111 crore, reflecting a 61% increase compared to the corresponding period last year. Growth was supported by improved realizations and solid performance across the Specialty Chemicals, Nutrition, and Chemical Intermediates segments.
How strong was Jubilant Ingrevia’s trading volume?
20.77 lakh shares traded, 8.45 times the 20-day average daily volume. The price and volume data are dated 27 October 2026 · 02:55 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.